Altimmune, Inc.
ALT
$2.91
-$0.02-0.68%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.26% | -18.02% | 16.77% | 10.12% | 19.75% |
| Total Depreciation and Amortization | -20.69% | -21.21% | -27.03% | -50.82% | -72.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 36.31% | 83.50% | 65.02% | -24.62% | -1.57% |
| Change in Net Operating Assets | -2,827.40% | 46.83% | 155.23% | -93.38% | -98.61% |
| Cash from Operations | -24.36% | -6.48% | 56.13% | -6.86% | -2.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.07% | -680.67% | -12,553.79% | 2,835.85% | 87.09% |
| Cash from Investing | 27.66% | -680.68% | -12,553.79% | 2,835.58% | 87.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 126.98% | 511.13% | 14,592.96% | 19,004.55% | 10,200.29% |
| Repurchase of Common Stock | -2.51% | -1,150.00% | 100.00% | 97.54% | -13.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 26.45% | -- | -- | -- | -- |
| Cash from Financing | 130.00% | 704.46% | 14,692.86% | 113,673.91% | 13,172.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 342.12% | -420.54% | -375.07% | 713.28% | 121.69% |